885223-72-3

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-6-methyl-1H-indazole is used as a building block for the synthesis of pharmaceuticals due to its heterocyclic nature and reactivity. It can be incorporated into the molecular structures of new drugs, potentially enhancing their therapeutic properties and effectiveness.
Used in Agrochemical Industry:
5-Bromo-6-methyl-1H-indazole is used as a building block for the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure and reactivity can contribute to the development of more effective and environmentally friendly agrochemicals.
Used in Medicinal Chemistry Research:
5-Bromo-6-methyl-1H-indazole is used as a valuable component in the development of new drugs and research in the field of medicinal chemistry. Its properties and reactivity make it an important chemical for further study and potential applications in drug discovery.
Used in Organic Chemistry Research:
5-Bromo-6-methyl-1H-indazole is used in organic chemistry research for its potential to undergo various chemical reactions and transformations. This allows chemists to explore new synthetic routes and develop novel compounds with potential applications in various industries.

InChI:InChI=1/C8H7BrN2/c1-5-2-8-6(3-7(5)9)4-10-11-8/h2-4H,1H3,(H,10,11)

Upstream product

• 95-78-3 2,5-Dimethylaniline 
• 2050-44-4 N-(2,5-dimethylphenyl)acetamide 
• 13711-31-4 N-(4-bromo-2,5-dimethyl-phenyl)acetamide 
• 1202527-94-3 1-acetyl-5-bromo-6-methyl-1H-indazole 
• 30273-40-6 4-bromo-2,5-dimethylaniline 
• 540-80-7 tert.-butylnitrite 

Downstream Products

• 1202528-03-7 5-bromo-1-(4-fluorophenyl)-6-methyl-1H-indazole 
• 1202527-96-5 Propyl-6-bromomethyl-1-methyl-1H-indazole-5-carboxylate 
• 1202527-98-7 1-methyl-6-phenoxymethyl-1H-indazole-5-carboxylic acid 
• 1202526-93-9 (E)-5-{1-[3-(methanesulfonamide)phenyl]propylidene}-1-methyl-5,11-dihydrobenzo[6,7]oxepino[4,3-f]indazole 
• 1202527-97-6 n-propyl-1-methyl-6-phenoxymethyl-1H-indazole-5-carboylate 
• 259537-71-8 6-Methyl-1 H-indazole-5-carbonitrile 
• 1312009-23-6 ethyl 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-methyl-1H-indazol-1-yl]butanoate 
• 1312009-24-7 ethyl 4-[5-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-methyl-1H-indazol-1-yl]butanoate 
• 1312009-58-7 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-methyl-1H-indazol-1-yl]butanoic acid 
• 1312009-59-8 4-[5-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-6-methyl-1H-indazol-1-yl]butanoic acid 
• 1467061-53-5 5-(2-fluoro-4-methoxyphenyl)-6-methyl-2-((2-(trimethylsilyl)ethoxy)methyl)-2H-indazole 
• 1467061-54-6 ethyl 5-(2-fluoro-4-methoxyphenyl)-6-methyl-2-((2-(trimethylsilyl)ethoxy)methyl)-2H-indazole-3-carboxylate 
• 1467061-55-7 ethyl 5-(2-fluoro-4-methoxyphenyl)-6-methyl-1H-indazole-3-carboxylate 
• 1467058-96-3 5-(2-fluoro-4-methoxyphenyl)-6-methyl-1H-indazole-3-carboxylic acid 

Relevant academic research and scientific papers

GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT

The present invention relates to a novel compound having GPR40 receptor agonist activity that promotes insulin secretion and inhibits blood sugar rise after glucose loading, and is thereby useful for the treatment of diabetes and complications thereof, the preparation method thereof and pharmaceutical composition containing them as an active ingredient.

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptor are disclosed.

TETRACYCLIC COMPOUND

Provided are a tetracyclic compound represented by the formula (I): [in the formula(I),the formula (A) represents a benzene ring or the like, X represents CH or a nitrogen atom, Q represents -O- or the like, R1, R2, and R3 may be the same or different and each represent a hydrogen atom or the like, 1, m, and n each represent an integer from one to the maximum substitutable number of substituents, and R4 and R5 may be the same or different and each represent a hydrogen atom or the like], or a pharmaceutically acceptable salt thereof, and the like.

THIADIAZOLE COMPOUNDS AND METHODS OF USE

The invention relates to thiadiazole compounds useful for treating diseases mediated by protein kinase B (PKB). The invention also relates to the therapeutic use of such thiadiazole compounds and compositions thereof in treating disease states associated